Less than four years after Walgreen (WAG) and rival drugstores like CVS/Caremark Corp.  (CVS) began a lobbying blitz with state regulators to allow pharmacists to administer seasonal influenza shots, pharmacies are beginning to see benefits of the strategy in their bottom lines.